Work has started on developing a flexible insulin patch pump that people with diabetes can wear on their skin like a plaster.
Type 1 diabetes charity JDRF has partnered with US medical technology start-up Med Cam to develop the Evopump, which will be the size of a business card and just six millimetres thick.
The pump’s flexible material means it can be worn over the skin, with thin materials encased inside the pump helping to deliver precise amounts of insulin through a cannula.
JDRF says the Evopump will make it easier for people with diabetes to administer insulin because it will be more comfortable and discreet than existing pumps.
It has been estimated that once fully working, the device may be worn for up to a week at a time.
Dr Jaime Giraldo, JDRF program scientist for research, said: “The Evopump represents the type of miniaturised and user-centric design that could substantially reduce the burden of living with type 1 diabetes and remove obstacles preventing some people, particularly children, from using devices that could improve their glucose management.”
The Evopump is likely to appeal to people who are put off wearing insulin pumps because of their size, visibility and cost.
Researchers are now working hard on developing technology that will oversee the precise delivery of insulin, ensuring it is small enough so it can be encased within the flexible material of the device.
Larry Alberts, Cam Med’s chief executive officer, said: “This partnership with JDRF enables Cam Med to accelerate the development and commercialisation of the Evopump, and we’re looking forward to it becoming the core delivery platform for future [artificial pancreas] systems.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…